News | News By Subject | News by Disease News By Date | Search News

Diarrhea News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract     11/16/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy     6/8/2016
Exciting Time for Biotech in New Jersey     6/29/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Actelion Ltd. (ALIOF.PK)'s Diarrhea Treatment Gets Fast-Track From The FDA     3/3/2014
FDA Approves Salix Pharmaceuticals, Ltd. (SLXP)'s Diarrhea Drug for HIV/AIDS Patients     1/3/2013
Santarus Inc. (SNTS) Says Diarrhea Drug Meets Goal in Phase III Study     9/12/2012
Salix Pharmaceuticals, Ltd. (SLXP)'s Dragon's Blood Drug for Diarrhea Delayed by FDA     9/6/2012
Ocera Therapeutics, Inc. Receives CE Mark for Zysa™ for the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-d)     5/18/2012
Watson Pharmaceuticals, Inc. (WPI)'s Generic VANCOCIN® HCl Capsules Receive FDA Approval     4/10/2012
Furiex Pharmaceuticals, Inc. (FURX) Reports Positive Phase 2 Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome     9/7/2011
Update: Napo Pharmaceuticals, Inc. Files Suit Against Salix Pharmaceuticals, Ltd. (SLXP) for Breach of Contract Pertaining to Lead Drug Candidate     5/9/2011
Optimer Pharmaceuticals, Inc. (OPTR) Halts Study After Pruvel, an Antibiotic for Traveler’s Diarrhea, Linked to Rash     11/11/2010

News from Around the Web
Concerns Grow Over Getting High On Anti-Diarrheal Drug, Published In Annals Of Emergency Medicine     5/5/2016
Birth Of The $1 Diarrhea Vaccine     3/28/2016
When Good Gut Bacteria Get Sick, Brigham and Women's Hospital Study     7/14/2014
Severe Diarrhea Linked To Antibiotics Prescribed In Doctor's Offices, Centers for Disease Control and Prevention (CDC) Reveals     3/10/2014
C. Difficile Yields to Novel Antibiotic, University of Calgary Study     2/3/2011
Scientists Fight Bugs with Poo, University of Minnesota Study     1/19/2011
Proton Pump Inhibitors Linked to Clostridium difficile-Associated Diarrhea: Presented at AAFP, Saint Joseph Regional Medical Center Study     10/6/2010
Scientists Target Possible Cause of One Form of Bowel Disease, Ohio State University Study     8/3/2010
Octreotide Acetate (Sandostatin) Does Not Prevent Treatment-Induced Diarrhea In Anorectal Cancer, Radiation Therapy Oncology Group Research     3/25/2010
Cause Of Common Chronic Diarrhea Revealed In New Research, Imperial College London, King's College London, and University of Edinburgh Study     11/6/2009
Budesonide is Not Beneficial for the Treatment of Diarrhea in Metastatic Melanoma Patients Receiving Ipilimumab, H. Lee Moffitt Cancer Center & Research Institute Study     8/12/2009
Kefir, Although Rich in Probiotics, Did Not Prevent Diarrhea in Children Using Antibiotics, Georgetown University Medical Center Researchers Say     8/4/2009
New Trial Casts Doubt On Role Of Zinc Supplements In Diarrhea Treatment, Lata Medical Research Foundation Study     5/11/2009
Vaccine For Traveler's Diarrhea May Be Within Reach, Naval Medical Research Center Study     4/17/2009
New Optimer Pharmaceuticals, Inc. Drug Treats Traveler's Diarrhea, University of Texas Study     10/29/2008

Press Releases
Allergan (AGN) Receives Positive Opinion For Truberzi (Eluxadoline) For Treatment Of Irritable Bowel Syndrome With Diarrhoea (IBS-D) In Adults     7/25/2016
Jaguar Animal Health Obtains Protocol Concurrence From FDA For Canalevia Drug Product Candidate For Treatment Of Acute Diarrhea In Dogs     4/13/2016
Synthetic Biologics (SYN) Announces Further U.S. Patent Successes Covering SYN-004 Intended For The Prevention Of C. Difficile Infection And Antibiotic-Associated Diarrhea     3/1/2016
Ironwood (IRWD) Details Strategy To Build Top-Performing Commercial Biotechnology Company     1/11/2016
Jaguar Animal Health Initiates University Pilot Safety Study To Evaluate Use Of Crofelemer For The Treatment Of Diarrhea Associated With Acute Colitis In Horses     12/3/2015
BioGaia’s Probiotic Shown To Promote Growth And Prevent Recurrent Diarrhoea     10/12/2015
Syntethic Biologics, Inc. Reports Second Quarter 2015 Financial Results And Operational Highlights     8/10/2015
Salix (SLXP) Announces FDA Approval of Xifaxan 550 mg For The Treatment Of IBS-D (Irritable Bowel Syndrome With Diarrhea)     5/28/2015
Zealand Pharma  (ZEAL.CO) And Helsinn Healthcare SA Announce The Advance Of Elsiglutide Into Phase IIB Development For The Prevention Of Chemotherapy-Induced Diarrhea     2/5/2015
Cubist Pharmaceuticals, Inc. (CBST) To Present New Data From Study Of Fidaxomicin In Children With Clostridium Difficile-Associated Diarrhea At IDWeek 2014     10/8/2014
Zoetis (ZTS) Granted Conditional License For Porcine Epidemic Diarrhea Vaccine*     9/3/2014
Rebiotix Completes Enrollment In Phase 2 Clinical Trial Of New Drug For The Treatment Of Recurrent Clostridium Difficile-Associated Diarrhea     1/13/2014
Rebiotix Begins Clinical Trial of Therapy for the Treatment of Recurrent Clostridium difficile-Associated Diarrhea     10/16/2013
Santarus Inc. (SNTS) Announces Presentation of Phase 3 Data for Rifamycin SV MMX in Travelers’ Diarrhea     10/4/2013
Furiex Pharmaceuticals, Inc. (FURX) Announces Completion of Patient Enrollment for Its Phase III Clinical Trials of Eluxadoline for IBS-d     7/15/2013

//-->